1448718-23-7

Basic information

• Product Name: 3-(2-benzyloxy-propionylamino)-3H-imidazole-4-carboxylic acid methyl ester
• Synonyms: 3-(2-benzyloxy-propionylamino)-3H-imidazole-4-carboxylic acid methyl ester
• CAS NO: 1448718-23-7
• Molecular Weight: 303.318
• Mol File: 1448718-23-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-(2-benzyloxy-propionylamino)-3H-imidazole-4-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(2-benzyloxy-propionylamino)-3H-imidazole-4-carboxylic acid methyl ester(1448718-23-7)
• EPA Substance Registry System: 3-(2-benzyloxy-propionylamino)-3H-imidazole-4-carboxylic acid methyl ester(1448718-23-7)

Safety Data

• Hazardous Substances Data: 1448718-23-7(Hazardous Substances Data)

Upstream product

• 17325-26-7 1H-imidazole-5-carboxylic acid methyl ester 
• 865444-80-0 3-amino-3H-imidazole-4-carboxylic acid methyl ester 
• 33106-32-0 2-(benzyloxy)propanoic acid 

Downstream Products

• 1448718-24-8 3-(2-benzyloxy-propionylamino)-3H-imidazole-4-carboxylic acid amide 
• 1448718-25-9 2-(1-benzyloxy-ethyl)-3H-imidazo[5,1-f][1,2,4]triazin-4-one 
• 1448718-26-0 2-(1-benzyloxy-ethyl)-7-iodo-3H-imidazo[5,1-f][1,2,4]triazin-4-one 
• 1448718-27-1 2-(1-benzyloxy-ethyl)-7-(3,6-dihydro-2H-pyran-4-yl)-3H-imidazo[5,1-f][1,2,4]triazin-4-one 
• 1448717-37-0 2-[3-(4-fluoro-phenoxy)-azetidin-1-ylmethyl]-7-(tetrahydro-pyran-4-yl)-3H-imidazo[5,1-f][1,2,4]triazin-4-one 
• 1448717-51-8 2-{1-[3-(4-methoxy-phenyl)-azetidin-1-yl]-ethyl}-7-(tetrahydro-pyran-4-yl)-3H-imidazo[5,1-f][1,2,4]triazin-4-one 

Relevant articles and documents

PDE9 inhibitors with imidazo triazinone backbone

This invention is directed to compounds, which are PDE9 enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I).